Company
Cochlear Limited
Headquarters: Sydney, NSW, Australia
Founded: 1981
Employees: 4,000
CEO: Mr. Diggory William Howitt BE (Hons), MBA
Market Cap
A$20.88 Billion
AUD as of July 1, 2024
US$13.90 Billion
Cochlear Limited Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Cochlear Limited has the following listings and related stock indices.
Stock: ASX: COH wb_incandescent
Product & Services
Cochlear implantsBone-anchored hearing aidsCochlear wireless accessoriesBone anchored prosthetics
Key People
Dig Howitt (CEO) Rick Holliday- Smith (Chairman)
Financials
Revenue: A$1240 million (2017)
Net income: A$224 million (2017)